Cargando…

Systemic delivery of TLR9-activating/STAT3-blocking oligonucleotides induces leukemia regression

Detalles Bibliográficos
Autores principales:	Zhang, Qifang, Md Sakib Hossain, Dewan, Nechaev, Sergey, Buettner, Ralf, Swiderski, Piotr, Jozwiak, Agnieszka, Forman, Stephen J, Bhatia, Ravi, Kuo, Ya-Huei, Kortylewski, Marcin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288391/ http://dx.doi.org/10.1186/2051-1426-2-S3-P107

Ejemplares similares

Cell-selective oligonucleotide STAT3 inhibitor for immunotherapy of human acute myeloid leukemia
por: Zhang, Qifang, et al.
Publicado: (2015)

Targeted TLR9-activation/STAT3-blocking abrogates immunosuppressive functions of myeloid-derived suppressor cells from late-stage prostate cancer patients
por: Md Sakib Hossain, Dewan, et al.
Publicado: (2014)

TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells
por: Moreira, Dayson, et al.
Publicado: (2015)

B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors
por: Zhao, Xingli, et al.
Publicado: (2018)

Glioma-targeted delivery of exosome-encapsulated antisense oligonucleotides using neural stem cells
por: Adamus, Tomasz, et al.
Publicado: (2021)

Push and release: TLR9 activation plus STAT3 blockade for systemic antitumor immunity
por: Kortylewski, Marcin, et al.
Publicado: (2014)

TLR agonist–Stat3 siRNA conjugates: cell-specific gene silencing and enhanced antitumor immune responses
por: Kortylewski, Marcin, et al.
Publicado: (2009)

The revival of CpG oligonucleotide-based cancer immunotherapies
por: Adamus, Tomasz, et al.
Publicado: (2018)

The dark side of Toll-like receptor signaling: TLR9 activation limits the efficacy cancer radiotherapy
por: Kortylewski, Marcin, et al.
Publicado: (2014)

Stat3-induced S1PR1 expression is critical for persistent Stat3 activation in tumors
por: Lee, Heehyoung, et al.
Publicado: (2010)

STAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity
por: Su, Yu-Lin, et al.
Publicado: (2018)

IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
por: Wang, Lin, et al.
Publicado: (2009)

Poly-Thymidine Oligonucleotides Mediate Activation of Murine Glial Cells Primarily Through TLR7, Not TLR8
por: Du, Min, et al.
Publicado: (2011)

Rational design of antisense oligonucleotides modulating the activity of TLR7/8 agonists
por: Alharbi, Arwaf S, et al.
Publicado: (2020)

An All-Nanocrystal Biosensing System for In Vitro Detection of STAT3 Oligonucleotides
por: Kong, Wei, et al.
Publicado: (2017)

Guanine-Modified Inhibitory Oligonucleotides Efficiently Impair TLR7- and TLR9-Mediated Immune Responses of Human Immune Cells
por: Römmler, Franziska, et al.
Publicado: (2015)

Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients
por: Sampath, Sagus, et al.
Publicado: (2018)

Prevalence of Child Functional Difficulties and Its Associated Factors in Bangladesh: An Application of Count Regression Model
por: Habib, Md. Jakaria, et al.
Publicado: (2022)

Evolutionary Regression and Species-Specific Codon Usage of TLR15
por: Voogdt, Carlos G. P., et al.
Publicado: (2018)

STAT3 Oligonucleotide Inhibits Tumor Angiogenesis in Preclinical Models of Squamous Cell Carcinoma
por: Klein, Jonah D., et al.
Publicado: (2014)

Classification, Mechanisms of Action, and Therapeutic Applications of Inhibitory Oligonucleotides for Toll-Like Receptors (TLR) 7 and 9
por: Lenert, Petar S.
Publicado: (2010)

CpG oligonucleotides bind TLR9 and RRM-Containing proteins in Atlantic Salmon (Salmo salar)
por: Iliev, Dimitar B, et al.
Publicado: (2013)

demuxmix: Demultiplexing oligonucleotide-barcoded single-cell RNA sequencing data with regression mixture models
por: Klein, Hans-Ulrich
Publicado: (2023)

demuxmix: demultiplexing oligonucleotide-barcoded single-cell RNA sequencing data with regression mixture models
por: Klein, Hans-Ulrich
Publicado: (2023)

Sequence-dependent inhibition of cGAS and TLR9 DNA sensing by 2′-O-methyl gapmer oligonucleotides
por: Valentin, Roxane, et al.
Publicado: (2021)

Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics
por: Buss, Colin G., et al.
Publicado: (2020)

HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
por: Curtin, James F, et al.
Publicado: (2009)

Cyclophosphamide in combination with tumor lysate and TLR9 ligand regresses murine neuroblastoma
por: Gershan, Jill, et al.
Publicado: (2013)

The Interplay of Notch Signaling and STAT3 in TLR-Activated Human Primary Monocytes
por: Hildebrand, Dagmar, et al.
Publicado: (2018)

Oligonucleotide-based strategies to combat polyglutamine diseases
por: Fiszer, Agnieszka, et al.
Publicado: (2014)

Unbiased Prediction and Feature Selection in High-Dimensional Survival Regression
por: Laimighofer, Michael, et al.
Publicado: (2016)

STAT1 deficiency redirects IFN signalling toward suppression of TLR response through a feedback activation of STAT3
por: Kim, Hun Sik, et al.
Publicado: (2015)

STAT3 decoy oligonucleotide-carrying microbubbles with pulsed ultrasound for enhanced therapeutic effect in head and neck tumors
por: Ramasamy, Thiruganesh, et al.
Publicado: (2020)

A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB
por: Souissi, Inès, et al.
Publicado: (2011)

Aberrant Expression of TLR2, TLR7, TLR9, Splicing Variants of TLR4 and MYD88 in Chronic Lymphocytic Leukemia Patients
por: Skorka, Katarzyna, et al.
Publicado: (2021)

Bone Marrow Niche Trafficking of miR-126 Controls Self-Renewal of Leukemia Stem Cells in Chronic Myelogenous Leukemia
por: Zhang, Bin, et al.
Publicado: (2018)

TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
por: Reilley, Matthew J., et al.
Publicado: (2019)

Withacnistin inhibits recruitment of STAT3 and STAT5 to growth factor and cytokine receptors and induces regression of breast tumours
por: Zhang, X, et al.
Publicado: (2014)

A Naturally Occurring Variant in Human TLR9, P99L, Is Associated with Loss of CpG Oligonucleotide Responsiveness
por: Kubarenko, Andriy V., et al.
Publicado: (2010)

Orally administered BZL-sRNA-20 oligonucleotide targeting TLR4 effectively ameliorates acute lung injury in mice
por: Zhao, Dandan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uua0s5gn7jkhrcup0tl44c6sb2